X4 Pharmaceuticals Inc (XFOR)
0.99
+0.03
(+3.12%)
USD |
NASDAQ |
Jun 26, 11:36
X4 Pharmaceuticals Cash from Investing (Quarterly): -5.322M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -5.322M |
| December 31, 2023 | -4.833M |
| September 30, 2023 | -5.157M |
| June 30, 2023 | -4.884M |
| March 31, 2023 | -0.009M |
| December 31, 2022 | -0.034M |
| September 30, 2022 | -0.009M |
| June 30, 2022 | -0.038M |
| March 31, 2022 | -0.022M |
| December 31, 2021 | -0.013M |
| September 30, 2021 | -0.02M |
| June 30, 2021 | -0.086M |
| March 31, 2021 | -0.496M |
| December 31, 2020 | -0.302M |
| September 30, 2020 | -0.496M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.009M |
| March 31, 2020 | -0.555M |
| December 31, 2019 | 0.021M |
| September 30, 2019 | 0.815M |
| June 30, 2019 | -0.01M |
| March 31, 2019 | 26.41M |
| December 31, 2018 | 0.034M |
| September 30, 2018 | -0.007M |
| June 30, 2018 | -0.027M |
| March 31, 2018 | |
| December 31, 2017 | 0.017M |
| September 30, 2017 | -0.018M |
| June 30, 2017 | -0.024M |
| March 31, 2017 | -0.017M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-5.322M
Minimum
Mar 2024
0.815M
Maximum
Sep 2019
-1.073M
Average
-0.036M
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -217.00M |
| Ironwood Pharmaceuticals Inc | -0.068M |
| Ocular Therapeutix Inc | -0.255M |
| Scholar Rock Holding Corp | 33.38M |
| RAPT Therapeutics Inc | 15.89M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -33.60M |
| Free Cash Flow | -103.71M |
| Free Cash Flow Per Share (Quarterly) | -0.1683 |
| Free Cash Flow Yield | -54.79% |